Pathway analysis of a genome-wide association study of ileal Crohn's disease

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The aim of this study was to identify the candidate single-nucleotide polymorphisms (SNPs) and candidate mechanisms of Crohn's disease (CD) and to generate a SNP to gene to pathway hypothesis using a pathway-based approach, ICSNPathway (Identify candidate Causal SNPs and Pathways) of genome-wide association studies (GWAS). An ileal CD GWAS dataset downloaded from NCBI dbGap was used in this study, which was conducted using 297,857 SNPs in 968 CD cases and 995 controls after quality control filtering. ICSNPathway analysis was applied to the CD GWAS dataset. ICSNPathway analysis identified seven candidate SNPs, nine pathways, which provided five hypothetical biological mechanisms. First, rs4077515 to caspase recruitment domain-containing protein 9 (CARD9) to response to peptidoglycan, positive regulation of tumor necrosis factor production, response to exogenous dsRNA, positive regulation of interleukin-6 production, and positive regulation of innate immune response (nominal p≤0.002, false discovery rate [FDR]=0.027). Second, rs2066842, rs3135500, and rs5743291 to NOD2 to response to pepditoglycan, innate immune response activating signal transduction, and positive regulation of innate immune response (nominal p≤0.001, FDR=0.027). Third, rs8172678 to PPARGC1A to cellular glucose homeostasis (nominal p<0.001, FDR=0.031). Fourth, rs1050152 to SLC22A4 to cofactor transporter activity and vitamin transport (nominal p<0.001, FDR=0.044). Fifth, rs9621049 to TCN2 to vitamin transport (nominal p<0.001, FDR=0.046). In conclusion, by applying ICSNPathway analysis to CD GWAS, we identified candidate SNPs, genes involving CARD9, NOD2, PPARGC1A, SLC22A4, and TCN2, pathways, and hypothetical mechanisms, which may contribute to ileal CD susceptibility.

Original languageEnglish
Pages (from-to)1549-1554
Number of pages6
JournalDNA and Cell Biology
Volume31
Issue number10
DOIs
Publication statusPublished - 2012 Oct 1

Fingerprint

Ileal Diseases
Genome-Wide Association Study
Crohn Disease
Single Nucleotide Polymorphism
Innate Immunity
Vitamins
Peptidoglycan
Disease Susceptibility
Quality Control
Genes
Interleukin-6
Signal Transduction
Proteins
Homeostasis
Tumor Necrosis Factor-alpha

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Pathway analysis of a genome-wide association study of ileal Crohn's disease. / Lee, Young Ho; Song, Gwan Gyu.

In: DNA and Cell Biology, Vol. 31, No. 10, 01.10.2012, p. 1549-1554.

Research output: Contribution to journalArticle

@article{459befe4a5ce4de6b48523cf0d7c0299,
title = "Pathway analysis of a genome-wide association study of ileal Crohn's disease",
abstract = "The aim of this study was to identify the candidate single-nucleotide polymorphisms (SNPs) and candidate mechanisms of Crohn's disease (CD) and to generate a SNP to gene to pathway hypothesis using a pathway-based approach, ICSNPathway (Identify candidate Causal SNPs and Pathways) of genome-wide association studies (GWAS). An ileal CD GWAS dataset downloaded from NCBI dbGap was used in this study, which was conducted using 297,857 SNPs in 968 CD cases and 995 controls after quality control filtering. ICSNPathway analysis was applied to the CD GWAS dataset. ICSNPathway analysis identified seven candidate SNPs, nine pathways, which provided five hypothetical biological mechanisms. First, rs4077515 to caspase recruitment domain-containing protein 9 (CARD9) to response to peptidoglycan, positive regulation of tumor necrosis factor production, response to exogenous dsRNA, positive regulation of interleukin-6 production, and positive regulation of innate immune response (nominal p≤0.002, false discovery rate [FDR]=0.027). Second, rs2066842, rs3135500, and rs5743291 to NOD2 to response to pepditoglycan, innate immune response activating signal transduction, and positive regulation of innate immune response (nominal p≤0.001, FDR=0.027). Third, rs8172678 to PPARGC1A to cellular glucose homeostasis (nominal p<0.001, FDR=0.031). Fourth, rs1050152 to SLC22A4 to cofactor transporter activity and vitamin transport (nominal p<0.001, FDR=0.044). Fifth, rs9621049 to TCN2 to vitamin transport (nominal p<0.001, FDR=0.046). In conclusion, by applying ICSNPathway analysis to CD GWAS, we identified candidate SNPs, genes involving CARD9, NOD2, PPARGC1A, SLC22A4, and TCN2, pathways, and hypothetical mechanisms, which may contribute to ileal CD susceptibility.",
author = "Lee, {Young Ho} and Song, {Gwan Gyu}",
year = "2012",
month = "10",
day = "1",
doi = "10.1089/dna.2012.1605",
language = "English",
volume = "31",
pages = "1549--1554",
journal = "DNA and Cell Biology",
issn = "1044-5498",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Pathway analysis of a genome-wide association study of ileal Crohn's disease

AU - Lee, Young Ho

AU - Song, Gwan Gyu

PY - 2012/10/1

Y1 - 2012/10/1

N2 - The aim of this study was to identify the candidate single-nucleotide polymorphisms (SNPs) and candidate mechanisms of Crohn's disease (CD) and to generate a SNP to gene to pathway hypothesis using a pathway-based approach, ICSNPathway (Identify candidate Causal SNPs and Pathways) of genome-wide association studies (GWAS). An ileal CD GWAS dataset downloaded from NCBI dbGap was used in this study, which was conducted using 297,857 SNPs in 968 CD cases and 995 controls after quality control filtering. ICSNPathway analysis was applied to the CD GWAS dataset. ICSNPathway analysis identified seven candidate SNPs, nine pathways, which provided five hypothetical biological mechanisms. First, rs4077515 to caspase recruitment domain-containing protein 9 (CARD9) to response to peptidoglycan, positive regulation of tumor necrosis factor production, response to exogenous dsRNA, positive regulation of interleukin-6 production, and positive regulation of innate immune response (nominal p≤0.002, false discovery rate [FDR]=0.027). Second, rs2066842, rs3135500, and rs5743291 to NOD2 to response to pepditoglycan, innate immune response activating signal transduction, and positive regulation of innate immune response (nominal p≤0.001, FDR=0.027). Third, rs8172678 to PPARGC1A to cellular glucose homeostasis (nominal p<0.001, FDR=0.031). Fourth, rs1050152 to SLC22A4 to cofactor transporter activity and vitamin transport (nominal p<0.001, FDR=0.044). Fifth, rs9621049 to TCN2 to vitamin transport (nominal p<0.001, FDR=0.046). In conclusion, by applying ICSNPathway analysis to CD GWAS, we identified candidate SNPs, genes involving CARD9, NOD2, PPARGC1A, SLC22A4, and TCN2, pathways, and hypothetical mechanisms, which may contribute to ileal CD susceptibility.

AB - The aim of this study was to identify the candidate single-nucleotide polymorphisms (SNPs) and candidate mechanisms of Crohn's disease (CD) and to generate a SNP to gene to pathway hypothesis using a pathway-based approach, ICSNPathway (Identify candidate Causal SNPs and Pathways) of genome-wide association studies (GWAS). An ileal CD GWAS dataset downloaded from NCBI dbGap was used in this study, which was conducted using 297,857 SNPs in 968 CD cases and 995 controls after quality control filtering. ICSNPathway analysis was applied to the CD GWAS dataset. ICSNPathway analysis identified seven candidate SNPs, nine pathways, which provided five hypothetical biological mechanisms. First, rs4077515 to caspase recruitment domain-containing protein 9 (CARD9) to response to peptidoglycan, positive regulation of tumor necrosis factor production, response to exogenous dsRNA, positive regulation of interleukin-6 production, and positive regulation of innate immune response (nominal p≤0.002, false discovery rate [FDR]=0.027). Second, rs2066842, rs3135500, and rs5743291 to NOD2 to response to pepditoglycan, innate immune response activating signal transduction, and positive regulation of innate immune response (nominal p≤0.001, FDR=0.027). Third, rs8172678 to PPARGC1A to cellular glucose homeostasis (nominal p<0.001, FDR=0.031). Fourth, rs1050152 to SLC22A4 to cofactor transporter activity and vitamin transport (nominal p<0.001, FDR=0.044). Fifth, rs9621049 to TCN2 to vitamin transport (nominal p<0.001, FDR=0.046). In conclusion, by applying ICSNPathway analysis to CD GWAS, we identified candidate SNPs, genes involving CARD9, NOD2, PPARGC1A, SLC22A4, and TCN2, pathways, and hypothetical mechanisms, which may contribute to ileal CD susceptibility.

UR - http://www.scopus.com/inward/record.url?scp=84866991106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866991106&partnerID=8YFLogxK

U2 - 10.1089/dna.2012.1605

DO - 10.1089/dna.2012.1605

M3 - Article

C2 - 22957492

AN - SCOPUS:84866991106

VL - 31

SP - 1549

EP - 1554

JO - DNA and Cell Biology

JF - DNA and Cell Biology

SN - 1044-5498

IS - 10

ER -